László Lorenzovici
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 5
-
- Acute Ischemic Stroke Management 2
- Co-authors
- Marcell Csanádi (9 shared papers)Zoltán Kaló (13 shared papers)Tomáš Tesař (5 shared papers)András Inotai (3 shared papers)Guenka Ivanova Petrova (4 shared papers)Tomasz Bochenek (3 shared papers)Antal Tamás Zemplenyi (4 shared papers)Andrea Dorottya Székely (3 shared papers)
- Journals
- The Lancet (7 papers)Frontiers in Public Health (4 papers)Value in Health (2 papers)The Lancet Neurology (2 papers)The Lancet Infectious Diseases (2 papers)
- Partner nations
- RomaniaHungaryUnited States
In The Last Decade
László Lorenzovici
40 papers receiving 10.1k citations
László Lorenzovici's Hit Papers
Peers
Comparison fields: 5 of 199
- Applied Microbiology and Biotechnology 130
- Molecular Medicine 244
- Health, Toxicology and Mutagenesis 427
- Epidemiology 963
- Microbiology 184
Countries citing papers authored by László Lorenzovici
This map shows the geographic impact of László Lorenzovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Lorenzovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Lorenzovici more than expected).
Fields of papers citing papers by László Lorenzovici
This network shows the impact of papers produced by László Lorenzovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Lorenzovici. The network helps show where László Lorenzovici may publish in the future.
Co-authors
The 25 scholars most cited alongside László Lorenzovici, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 1486 |
| 3 | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1105 |
| 4 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 912 |
| 5 | The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 680 |
| 6 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 7 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 650 |
| 8 | Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2023 | 484 |
| 9 | Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 322 |
| 10 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 296 |
| 11 | Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 Hit paper breakdown → | 2022 | 213 |
| 12 | Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 Hit paper breakdown → | 2023 | 157 |
| 13 | 2024 | 59 | |
| 14 | 2022 | 51 | |
| 15 | Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 46 |
| 16 | Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 35 |
| 17 | 2024 | 28 | |
| 18 | 2018 | 27 | |
| 19 | 2023 | 20 | |
| 20 | 2021 | 19 |
About László Lorenzovici
László Lorenzovici is a scholar working on Economics and Econometrics, Epidemiology, Pediatrics, Perinatology and Child Health, Emergency Medicine and Immunology, having authored 41 papers that have together received 10.3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pharmaceutical Economics and Policy (5 papers), Biosimilars and Bioanalytical Methods (3 papers), COVID-19 and healthcare impacts (3 papers), Iron Metabolism and Disorders (2 papers), Global Maternal and Child Health (2 papers), Acute Ischemic Stroke Management (2 papers) and Heart Failure Treatment and Management (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (130 citations), Molecular Medicine (244 citations), Health, Toxicology and Mutagenesis (427 citations), Epidemiology (963 citations) and Microbiology (184 citations). László Lorenzovici has collaborated with scholars based in Romania, Hungary and United States. Frequent co-authors include Marcell Csanádi, Zoltán Kaló, Tomáš Tesař, András Inotai, Guenka Ivanova Petrova, Tomasz Bochenek, Antal Tamás Zemplenyi, Andrea Dorottya Székely, Leoš Fuksa and Péter Gaál. Their work appears in journals such as The Lancet, Frontiers in Public Health, Value in Health, The Lancet Neurology and The Lancet Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.